Published in Can J Microbiol on February 01, 1970
Bactericidal and bacteriolytic activity of serum against gram-negative bacteria. Microbiol Rev (1983) 5.73
The paradox of Hemophilus infuenzae type B bacteremia in the presence of serum bactericidal activity. J Clin Invest (1976) 1.94
Effects of serum components on gram-negative bacteria during bactericidal reactions. Infect Immun (1971) 1.39
Resistance of inbred mice to Salmonella typhimurium. J Infect Dis (1972) 4.32
Microbiologic aspects of chronic ambulatory peritoneal dialysis. Kidney Int (1983) 2.66
Continuous ambulatory peritoneal dialysis - 1981. Nephron (1982) 1.82
Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site. Perit Dial Int (1998) 1.78
Effect of nonspecific stimulation on the defense mechanisms of inbred mice. J Immunol (1975) 1.72
Microbiological diagnosis of peritonitis in patients on continuous ambulatory peritoneal dialysis. J Clin Microbiol (1985) 1.51
Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it. Perit Dial Int (2001) 1.47
Nystatin prophylaxis: its inability to prevent fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int (1999) 1.44
Subcapsular steatonecrosis in response to peritoneal insulin delivery: a clue to the pathogenesis of steatonecrosis in obesity. Mod Pathol (1989) 1.40
Effects of serum components on gram-negative bacteria during bactericidal reactions. Infect Immun (1971) 1.39
Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis, and bactericidal activity in vitro. Infect Immun (1981) 1.29
Differential regulation and expression of hyaluronan synthases in human articular chondrocytes, synovial cells and osteosarcoma cells. Biochem J (2001) 1.19
In vitro cytotoxicity and antibiotic activity of polymyxin B nonapeptide. Antimicrob Agents Chemother (1986) 1.12
Specific antibody-mediated effect on the immune response. Suppression and augmentation of the primary immune response in mice by different classes of antibodies. Immunology (1972) 1.11
Endotoxin sensitivity of inbred mouse strains. Can J Microbiol (1973) 1.05
Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol Dial Transplant (2001) 0.99
Effects of antibodies on L5178Y mouse leukemia cells cultured in vitro. Cancer Res (1970) 0.91
Staph aureus peritonitis in patients on continuous ambulatory peritoneal dialysis. Trans Am Soc Artif Intern Organs (1984) 0.90
Slow continuous hemodialysis for the management of complicated acute renal failure in an intensive care unit. Clin Nephrol (1988) 0.89
Response to hepatitis B vaccine in Canadian dental students. Lancet (1982) 0.88
Outcome of Pseudomonas aeruginosa exit-site and tunnel infections: a single center's experience. Adv Perit Dial (1999) 0.87
Renal cell carcinoma in peritoneal dialysis patients. Int Urol Nephrol (2003) 0.87
Comparison of "invasive" and "non-invasive" strains of Staphylococcus epidermidis by phage typing. Zentralbl Bakteriol Orig A (1978) 0.86
Isoelectric separation of mouse immunoglobulins. J Immunol (1970) 0.84
Management of abdominal aortic and iliac artery aneurysms by stent-graft implantation in a patient on CAPD. Clin Nephrol (2009) 0.82
Peritonitis in continuous ambulatory peritoneal dialysis. Making therapeutic decisions easier. Arch Intern Med (1987) 0.81
Resistance to mupirocin: no indication of it to date while using mupirocin ointment for prevention of Staphylococcus aureus exit-site infections in peritoneal dialysis patients. Perit Dial Int (1999) 0.81
Chronic peritoneal dialysis in octogenarians. Nephrol Dial Transplant (2001) 0.80
Growth inhibitory effects of adenosine 3',5'-monophosphate on mouse leukemia L-5178-Y-R cells in culture. Experientia (1971) 0.80
Biocompatibility of silver-coated peritoneal dialysis catheter in a porcine model. Perit Dial Int (1997) 0.77
The effect of small solute clearances on survival of anuric peritoneal dialysis patients. Perit Dial Int (2000) 0.77
Recurrence of hyperparathyroidism after total parathyroidectomy and autotransplantation in peritoneal dialysis patients. Perit Dial Int (2000) 0.75
Effects of endotoxin on carbohydrate metabolism in inbred mice. Can J Comp Med (1976) 0.75
Successful treatment of systemic blastomycosis with high-dose ketoconazole in a renal transplant recipient. Am J Kidney Dis (1990) 0.75
The alphabet-soup of hepatitis. Perit Dial Int (1992) 0.75
A large step in the treatment of peritonitis in peritoneal dialysis patients. Perit Dial Int (1997) 0.75
Treatment of peritoneal dialysis catheter-related infections by simultaneous catheter removal and replacement. Is it safe? Perit Dial Int (1999) 0.75
Treatment of peritonitis: update or new course. Perit Dial Int (2001) 0.75
Continuous ambulatory peritoneal dialysis: no longer experimental. Can Med Assoc J (1984) 0.75
Treatment of peritonitis: how are we doing? Perit Dial Int (1995) 0.75
Treatment of fungal peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Am J Med (1990) 0.75
Studies on the production of complement. Immunology (1968) 0.75
Hepatitis B and the dental profession: response to hepatitis B vaccine in Canadian dental personnel. A study by the Canadian Red Cross Collaborative Group. J Infect (1983) 0.75
Handle with care: hepatitis B antigen carriers in peritoneal dialysis unit. Nephron (1981) 0.75
Long-term, intraperitoneal vancomycin in the prevention of recurrent peritonitis during CAPD: preliminary results. Perit Dial Int (1991) 0.75
Update on continuous ambulatory peritoneal dialysis. Ric Clin Lab (1984) 0.75
Effects of immunosuppressive drugs on secondary antibody response in vitro. Can J Microbiol (1968) 0.75
Etiology and treatment of peritonitis. Trans Am Soc Artif Intern Organs (1984) 0.75
Quantitation of macrophage activation. Acta Microbiol Hung (1983) 0.75
Inhibitory effects of anticellular antibodies on colony formation of mouse leukemia L5178YR cells in soft agar. Can J Microbiol (1972) 0.75
Importance of family contacts of HAA-positive persons. N Engl J Med (1972) 0.75
Vaccination for peritoneal dialysis patients. Perit Dial Int (1999) 0.75
VRE and empirical vancomycin for CAPD peritonitis: use at your own/patient's risk. Perit Dial Int (1998) 0.75
Prophylactic cephalexin ineffective in chronic ambulatory peritoneal dialysis. Lancet (1980) 0.75
Inhibition of RNA, DNA and protein synthesis by antisera in mouse leukemic cells L5178YR. Exp Cell Res (1972) 0.75
Is catheter function influenced by the side of the body in which the peritoneal dialysis catheter is placed? Perit Dial Int (2001) 0.75
Environmental protection and peritoneal dialysis garbage. Perit Dial Int (1991) 0.75
Heated sera and laboratory tests. Ann Intern Med (1985) 0.75
Local application of mupirocin at the peritoneal catheter exit site prevents early postoperative infections and should become standard practice. Perit Dial Int (2001) 0.75
Predicting success of vagus nerve stimulation (VNS) from interictal EEG. Seizure (2011) 0.75